Multi-laser metal printing and AI process optimization accelerate industrial additive manufacturing adoption.
SHANGHAI, May 18, 2026 /PRNewswire/ -- Unionfab, a digital manufacturing platform, further expands its industrial metal 3D printing services for customers in the United States, Canada and Germany. Powered by multi-laser industrial metal 3D printing systems and an AI-driven manufacturing platform, Unionfab can reduce selected low-volume metal parts production cycles from 30+ days to as fast as 5 days.
As demand grows for lightweight structures, complex geometries and faster product iteration, metal additive manufacturing is evolving from a high-end prototyping technology into an important method for industrial low-volume production. Meanwhile, maturing multi-laser printing systems, AI process optimization and metal powder supply chains are significantly improving metal 3D printing productivity and cost structure.
Unionfab, affiliated with UnionTech, an industrial 3D printing equipment manufacturer, has deployed 100+ industrial metal 3D printing systems, including four-laser and six-laser SLM systems now in scaled production. Compared with conventional dual-laser systems, the latest multi-laser platforms can increase printing efficiency by up to 40% while reducing manufacturing costs by approximately 30%.
Through proprietary AI process pre-compensation technology, Unionfab has achieved high-speed printing with a 0.6 mm layer thickness, improving production efficiency and reducing manufacturing costs while maintaining high density and consistent surface quality.
Unionfab supports various industrial-grade materials, including stainless steel (316L, 17-4PH), aluminum (AlSi10Mg, Al6061, Al901X), titanium (TC4), CuCrZr and Inconel (625, 718) etc. Its self-developed aerospace-grade high-strength aluminum alloy Al901X combines heat resistance, structural strength and anodizing compatibility, further enabling low-volume production of end-use aluminum alloy parts through metal 3D printing.
"Over the past few years, China's metal 3D printing industry has undergone rapid technological iteration and industrial maturation. Continuous innovation among equipment manufacturers, material supply chains and manufacturing service providers is driving rapid improvements in printing efficiency, process stability and overall manufacturing costs," Unionfab CEO Allen Yang pointed out. "We believe now is an important time for global manufacturers to reassess how they develop and produce complex metal parts."
With 1,000+ industrial 3D printers and 400+ CNC machines in house, Unionfab delivers end-to-end manufacturing services. By integrating 3D printing, CNC machining, injection molding, sheet metal, and rapid casting, the facility supports hardware developers from initial prototyping through full-scale production.
Learn more:
http://www.unionfab.com
Submit an RFQ online:
https://www.unionfab.com/order
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Unionfab Reduces Low-Volume Metal Parts Production from 30 Days to as Fast as 5 Days
|
Globally recognized Korean skincare brand strengthens its scientific leadership with veteran cosmetics R&D expert Alan Meyers.
NEW YORK, May 18, 2026 /PRNewswire/ -- Dr.Althea, the rapidly growing Korean skincare brand known for its viral 345 Relief Cream and barrier-focused skincare for sensitive skin, announced the appointment of Alan Meyers as Executive Scientific Advisor. The appointment strengthens Dr.Althea's position as a science-backed K-beauty brand focused on skin barrier health, sensitive skin solutions, and clinically informed skincare innovation.
With more than 40 years of experience in cosmetic research and development, Meyers is widely recognized as a leading expert in skincare formulation, cosmetic science, product development, and beauty innovation. Throughout his career, he has led research and development initiatives at major global beauty companies, including L'Oréal USA and Revlon, helping develop advanced skincare technologies, high-performance skincare formulations, and consumer-focused beauty products.
As Executive Scientific Advisor, Meyers will provide strategic scientific leadership to support Dr.Althea's continued expansion in the global skincare market. His work will focus on advancing dermatologist-inspired skincare formulations that support the skin barrier and address the evolving needs of consumers with sensitive, reactive, acne-prone, and compromised skin.
Meyers has already played a key role in the reformulation of Dr.Althea's best-selling 345 Relief Cream and 147 Barrier Cream. The updated formulations were developed using gentle, yet effective ingredients specifically selected for highly sensitive skin, acne-prone skin, and skin susceptible to fungal acne. The reformulations further reinforce Dr.Althea's commitment to non-irritating skincare, barrier repair, hydration, and long-term skin health.
"When you've worked in the beauty industry as long as I have, you see trends come and go," said Meyers. "Dr.Althea stands out because of its science-first approach to skincare, especially its commitment to developing effective products for sensitive skin without compromising ingredient integrity or skin compatibility."
Driven by rising global demand for Korean skincare and skin barrier-focused beauty products, Dr.Althea has experienced rapid international growth. The company reported a six-fold increase in annual sales revenue last year and achieved record Q1 sales of KRW 192 billion. Dr.Althea projects annual revenue will exceed KRW 700 billion by the end of 2026, positioning the brand among the fastest-growing K-beauty skincare companies worldwide.
Dr.Althea's hero product, the 345 Relief Cream, has surpassed 26 million units sold globally, fueled by strong consumer loyalty and high repurchase rates. The product has become especially popular among consumers seeking soothing skincare for redness, irritation, damaged skin barriers, and sensitive skin concerns.
With Meyers joining its Scientific Advisory Board, Dr.Althea continues to expand its leadership in the global K-beauty and derma skincare categories through ongoing scientific research, formulation innovation, and consumer-centered product development. Rooted in dermatological science and clean skincare principles, the brand aims to redefine long-term skin health by focusing on skin resilience, barrier support, and clinically minded skincare solutions.
"Dr.Althea is just getting started," Meyers added.
About Dr.Althea
Founded in 2014, Dr.Althea is a Korean derma skincare brand specializing in skincare for sensitive skin, compromised skin barriers, and irritation-prone skin. The brand has rapidly emerged as one of the fastest-growing names in global K-beauty.
Known for its clean, gentle, and dermatologist-inspired skincare formulations, Dr.Althea combines skin-soothing ingredients with advanced Korean skincare innovation to create effective products for sensitive and acne-prone skin types.
The brand gained international recognition through its bestselling 345 Relief Cream, which has surpassed 26 million units sold worldwide and achieved cult-favorite status among skincare consumers, beauty influencers, and K-beauty enthusiasts globally.
Dr.Althea has also received recognition from major beauty industry awards, including the Marie Claire US Skin Awards, and the Who What Wear UK Next in Beauty Awards.
As global demand for Korean skincare and barrier-repair skincare continues to grow, Dr.Althea is helping shape the future of modern K-beauty through science-backed formulations, clinically minded skincare innovation, and effective solutions for sensitive skin.
To learn more, visit Dr.Althea Global or follow Dr.Althea on Instagram at @dr.altheaglobal and TikTok at @dr.althea_official.
Globally recognized Korean skincare brand strengthens its scientific leadership with veteran cosmetics R&D expert Alan Meyers.
NEW YORK, May 18, 2026 /PRNewswire/ -- Dr.Althea, the rapidly growing Korean skincare brand known for its viral 345 Relief Cream and barrier-focused skincare for sensitive skin, announced the appointment of Alan Meyers as Executive Scientific Advisor. The appointment strengthens Dr.Althea's position as a science-backed K-beauty brand focused on skin barrier health, sensitive skin solutions, and clinically informed skincare innovation.
With more than 40 years of experience in cosmetic research and development, Meyers is widely recognized as a leading expert in skincare formulation, cosmetic science, product development, and beauty innovation. Throughout his career, he has led research and development initiatives at major global beauty companies, including L'Oréal USA and Revlon, helping develop advanced skincare technologies, high-performance skincare formulations, and consumer-focused beauty products.
As Executive Scientific Advisor, Meyers will provide strategic scientific leadership to support Dr.Althea's continued expansion in the global skincare market. His work will focus on advancing dermatologist-inspired skincare formulations that support the skin barrier and address the evolving needs of consumers with sensitive, reactive, acne-prone, and compromised skin.
Meyers has already played a key role in the reformulation of Dr.Althea's best-selling 345 Relief Cream and 147 Barrier Cream. The updated formulations were developed using gentle, yet effective ingredients specifically selected for highly sensitive skin, acne-prone skin, and skin susceptible to fungal acne. The reformulations further reinforce Dr.Althea's commitment to non-irritating skincare, barrier repair, hydration, and long-term skin health.
"When you've worked in the beauty industry as long as I have, you see trends come and go," said Meyers. "Dr.Althea stands out because of its science-first approach to skincare, especially its commitment to developing effective products for sensitive skin without compromising ingredient integrity or skin compatibility."
Driven by rising global demand for Korean skincare and skin barrier-focused beauty products, Dr.Althea has experienced rapid international growth. The company reported a six-fold increase in annual sales revenue last year and achieved record Q1 sales of KRW 192 billion. Dr.Althea projects annual revenue will exceed KRW 700 billion by the end of 2026, positioning the brand among the fastest-growing K-beauty skincare companies worldwide.
Dr.Althea's hero product, the 345 Relief Cream, has surpassed 26 million units sold globally, fueled by strong consumer loyalty and high repurchase rates. The product has become especially popular among consumers seeking soothing skincare for redness, irritation, damaged skin barriers, and sensitive skin concerns.
With Meyers joining its Scientific Advisory Board, Dr.Althea continues to expand its leadership in the global K-beauty and derma skincare categories through ongoing scientific research, formulation innovation, and consumer-centered product development. Rooted in dermatological science and clean skincare principles, the brand aims to redefine long-term skin health by focusing on skin resilience, barrier support, and clinically minded skincare solutions.
"Dr.Althea is just getting started," Meyers added.
About Dr.Althea
Founded in 2014, Dr.Althea is a Korean derma skincare brand specializing in skincare for sensitive skin, compromised skin barriers, and irritation-prone skin. The brand has rapidly emerged as one of the fastest-growing names in global K-beauty.
Known for its clean, gentle, and dermatologist-inspired skincare formulations, Dr.Althea combines skin-soothing ingredients with advanced Korean skincare innovation to create effective products for sensitive and acne-prone skin types.
The brand gained international recognition through its bestselling 345 Relief Cream, which has surpassed 26 million units sold worldwide and achieved cult-favorite status among skincare consumers, beauty influencers, and K-beauty enthusiasts globally.
Dr.Althea has also received recognition from major beauty industry awards, including the Marie Claire US Skin Awards, and the Who What Wear UK Next in Beauty Awards.
As global demand for Korean skincare and barrier-repair skincare continues to grow, Dr.Althea is helping shape the future of modern K-beauty through science-backed formulations, clinically minded skincare innovation, and effective solutions for sensitive skin.
To learn more, visit Dr.Althea Global or follow Dr.Althea on Instagram at @dr.altheaglobal and TikTok at @dr.althea_official.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Dr.Althea Expands Scientific Leadership With Global Cosmetic Industry Veteran
